Persons with dispensed medicines; background; 2006-2020
| Sex | Age | Background and generation | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|---|
| Total male and female | Total age | Total background and generation | A02 Drugs for acid related disorders | 2020 | 12.76 |
| Total male and female | Total age | Total background and generation | A02B Drugs for peptic ulcer and gord | 2020 | 12.76 |
| Total male and female | Total age | Total background and generation | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | A03 Drugs for funct.gastrointest.disord. | 2020 | 2.09 |
| Total male and female | Total age | Total background and generation | A03A Drugs for functional bowel disord. | 2020 | 0.53 |
| Total male and female | Total age | Total background and generation | A04 Antiemetics and antinauseants | 2020 | 0.46 |
| Total male and female | Total age | Total background and generation | A04A Antiemetics and antinauseants | 2020 | 0.46 |
| Total male and female | Total age | Total background and generation | A05C Bile therapy drugs and lipotropics | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | A10 Drugs used in diabetes | 2020 | 4.65 |
| Total male and female | Total age | Total background and generation | A10B Blood glucose lowering drugs, excl. | 2020 | 4.04 |
| Total male and female | Total age | Total background and generation | A10X Other drugs used in diabetes | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | A14 Anabolic agents for systemic use | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | C01D Vasodilators used in card. diseases | 2020 | 1.40 |
| Total male and female | Total age | Total background and generation | D01 Antifungals for dermatological use | 2020 | 4.42 |
| Total male and female | Total age | Total background and generation | D01A Antifungals for topical use | 2020 | 4.12 |
| Total male and female | Total age | Total background and generation | D01B Antifungals for systemic use | 2020 | 0.39 |
| Total male and female | Total age | Total background and generation | D05A Antipsoriatics for topical use | 2020 | 0.46 |
| Total male and female | Total age | Total background and generation | D05B Antipsoriatics for systemic use | 2020 | 0.05 |
| Total male and female | Total age | Total background and generation | D06 Antibiotics.. for dermatological use | 2020 | 3.85 |
| Total male and female | Total age | Total background and generation | D06A Antibiotics for topical use | 2020 | 3.15 |
| Total male and female | Total age | Total background and generation | D06B Chemotherapeutics for topical use | 2020 | 0.77 |
| Total male and female | Total age | Total background and generation | D10A Anti-acne preparations, topical use | 2020 | 0.87 |
| Total male and female | Total age | Total background and generation | D10B Anti-acne preparations,systemic use | 2020 | 0.16 |
| Total male and female | Total age | Total background and generation | G02B Contraceptives for topical use | 2020 | 0.09 |
| Total male and female | Total age | Total background and generation | G03A Hormonal contraceptives system. use | 2020 | 1.94 |
| Total male and female | Total age | Total background and generation | G04C Benign prostatic hypertrophy drugs | 2020 | 1.90 |
| Total male and female | Total age | Total background and generation | H02 Corticosteroids for systemic use | 2020 | 4.37 |
| Total male and female | Total age | Total background and generation | H02A Corticosteroids system.use, plain | 2020 | 4.32 |
| Total male and female | Total age | Total background and generation | H02B Corticosteroids system.use, combi. | 2020 | 0.06 |
| Total male and female | Total age | Total background and generation | J General antiinfectives for system.use | 2020 | 17.54 |
| Total male and female | Total age | Total background and generation | J01 Antibacterials for systemic use | 2020 | 16.12 |
| Total male and female | Total age | Total background and generation | J02 Antimycotics for systemic use | 2020 | 0.82 |
| Total male and female | Total age | Total background and generation | J02A Antimycotics for systemic use | 2020 | 0.82 |
| Total male and female | Total age | Total background and generation | J04A Drugs for treatment of tuberculosis | 2020 | 0.04 |
| Total male and female | Total age | Total background and generation | J04B Drugs for treatment of lepra | 2020 | 0.01 |
| Total male and female | Total age | Total background and generation | J05 Antivirals for systemic use | 2020 | 0.64 |
| Total male and female | Total age | Total background and generation | M05 Drugs for treatment of bone diseases | 2020 | 1.22 |
| Total male and female | Total age | Total background and generation | M09 Oth.drugs for musculo-skelet.disord. | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | M09A Oth.disord.musculoskelet.syst.drugs | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | N04 Anti-parkinson drugs | 2020 | 0.53 |
| Total male and female | Total age | Total background and generation | N06D Anti-dementia drugs | 2020 | 0.11 |
| Total male and female | Total age | Total background and generation | N07 Other nervous system drugs | 2020 | 0.81 |
| Total male and female | Total age | Total background and generation | N07B Drugs used in addictive disorders | 2020 | 0.37 |
| Total male and female | Total age | Total background and generation | N07X Other nervous system drugs | 2020 | 0.03 |
| Total male and female | Total age | Total background and generation | R01B Nasal decongestants, systemic use | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | R03 Drugs for obstruct. airway diseases | 2020 | 8.20 |
| Total male and female | Total age | Total background and generation | R03B Oth.obstruct.airway dis.drugs/inhal | 2020 | 3.19 |
| Total male and female | Total age | Dutch background | A02 Drugs for acid related disorders | 2020 | 13.75 |
| Total male and female | Total age | Dutch background | A02B Drugs for peptic ulcer and gord | 2020 | 13.75 |
| Total male and female | Total age | Dutch background | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | A03 Drugs for funct.gastrointest.disord. | 2020 | 2.10 |
| Total male and female | Total age | Dutch background | A03A Drugs for functional bowel disord. | 2020 | 0.54 |
| Total male and female | Total age | Dutch background | A04 Antiemetics and antinauseants | 2020 | 0.48 |
| Total male and female | Total age | Dutch background | A04A Antiemetics and antinauseants | 2020 | 0.48 |
| Total male and female | Total age | Dutch background | A05C Bile therapy drugs and lipotropics | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | A10 Drugs used in diabetes | 2020 | 4.55 |
| Total male and female | Total age | Dutch background | A10B Blood glucose lowering drugs, excl. | 2020 | 3.91 |
| Total male and female | Total age | Dutch background | A10X Other drugs used in diabetes | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | A14 Anabolic agents for systemic use | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | C01D Vasodilators used in card. diseases | 2020 | 1.52 |
| Total male and female | Total age | Dutch background | D01 Antifungals for dermatological use | 2020 | 4.34 |
| Total male and female | Total age | Dutch background | D01A Antifungals for topical use | 2020 | 4.05 |
| Total male and female | Total age | Dutch background | D01B Antifungals for systemic use | 2020 | 0.37 |
| Total male and female | Total age | Dutch background | D05A Antipsoriatics for topical use | 2020 | 0.47 |
| Total male and female | Total age | Dutch background | D05B Antipsoriatics for systemic use | 2020 | 0.06 |
| Total male and female | Total age | Dutch background | D06 Antibiotics.. for dermatological use | 2020 | 4.05 |
| Total male and female | Total age | Dutch background | D06A Antibiotics for topical use | 2020 | 3.33 |
| Total male and female | Total age | Dutch background | D06B Chemotherapeutics for topical use | 2020 | 0.80 |
| Total male and female | Total age | Dutch background | D10A Anti-acne preparations, topical use | 2020 | 0.74 |
| Total male and female | Total age | Dutch background | D10B Anti-acne preparations,systemic use | 2020 | 0.14 |
| Total male and female | Total age | Dutch background | G02B Contraceptives for topical use | 2020 | 0.10 |
| Total male and female | Total age | Dutch background | G03A Hormonal contraceptives system. use | 2020 | 2.22 |
| Total male and female | Total age | Dutch background | G04C Benign prostatic hypertrophy drugs | 2020 | 2.10 |
| Total male and female | Total age | Dutch background | H02 Corticosteroids for systemic use | 2020 | 4.76 |
| Total male and female | Total age | Dutch background | H02A Corticosteroids system.use, plain | 2020 | 4.71 |
| Total male and female | Total age | Dutch background | H02B Corticosteroids system.use, combi. | 2020 | 0.06 |
| Total male and female | Total age | Dutch background | J General antiinfectives for system.use | 2020 | 18.12 |
| Total male and female | Total age | Dutch background | J01 Antibacterials for systemic use | 2020 | 16.68 |
| Total male and female | Total age | Dutch background | J02 Antimycotics for systemic use | 2020 | 0.81 |
| Total male and female | Total age | Dutch background | J02A Antimycotics for systemic use | 2020 | 0.81 |
| Total male and female | Total age | Dutch background | J04A Drugs for treatment of tuberculosis | 2020 | 0.03 |
| Total male and female | Total age | Dutch background | J04B Drugs for treatment of lepra | 2020 | 0.01 |
| Total male and female | Total age | Dutch background | J05 Antivirals for systemic use | 2020 | 0.59 |
| Total male and female | Total age | Dutch background | M05 Drugs for treatment of bone diseases | 2020 | 1.40 |
| Total male and female | Total age | Dutch background | M09 Oth.drugs for musculo-skelet.disord. | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | M09A Oth.disord.musculoskelet.syst.drugs | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | N04 Anti-parkinson drugs | 2020 | 0.59 |
| Total male and female | Total age | Dutch background | N06D Anti-dementia drugs | 2020 | 0.13 |
| Total male and female | Total age | Dutch background | N07 Other nervous system drugs | 2020 | 0.84 |
| Total male and female | Total age | Dutch background | N07B Drugs used in addictive disorders | 2020 | 0.38 |
| Total male and female | Total age | Dutch background | N07X Other nervous system drugs | 2020 | 0.04 |
| Total male and female | Total age | Dutch background | R01B Nasal decongestants, systemic use | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | R03 Drugs for obstruct. airway diseases | 2020 | 8.59 |
| Total male and female | Total age | Dutch background | R03B Oth.obstruct.airway dis.drugs/inhal | 2020 | 3.46 |
| Total male and female | Total age | With migration background | A02 Drugs for acid related disorders | 2020 | 9.81 |
| Total male and female | Total age | With migration background | A02B Drugs for peptic ulcer and gord | 2020 | 9.81 |
| Total male and female | Total age | With migration background | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
| Total male and female | Total age | With migration background | A03 Drugs for funct.gastrointest.disord. | 2020 | 2.04 |
| Total male and female | Total age | With migration background | A03A Drugs for functional bowel disord. | 2020 | 0.52 |
| Total male and female | Total age | With migration background | A04 Antiemetics and antinauseants | 2020 | 0.38 |
| Source: CBS. | |||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.
Data are broken down by medicine group, background, generation, age and sex.
Data available from 2006 to 2020.
Status of the figures:
All figures are definite.
Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.
When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.